4.7 Article

Mechanism of cordycepin enhancing doxorubicin against hepatocellular carcinoma in vitro and in vivo

Related references

Note: Only part of the references are listed.
Review Oncology

Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?

Eleonora Lai et al.

Summary: Advanced hepatocellular carcinoma (HCC) is the most common type of liver cancer, and immunotherapy is considered a means of improving survival outcomes. Current research focuses on immune checkpoint inhibitors and other immunotherapy strategies, each with unique efficacy and toxicity profiles closely related to their mechanisms and tumor microenvironment.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Review Medicine, Research & Experimental

Cordycepin: A bioactive metabolite with therapeutic potential

Hardeep S. Tuli et al.

LIFE SCIENCES (2013)